1-(2-chloroethyl)-1-nitroso-3-(2-norb-ornyl)urea

Suppliers

Names

[ CAS No. ]:
13909-13-2

[ Name ]:
1-(2-chloroethyl)-1-nitroso-3-(2-norb-ornyl)urea

Chemical & Physical Properties

[ Density]:
1.52g/cm3

[ Molecular Formula ]:
C10H16ClN3O2

[ Molecular Weight ]:
245.70600

[ Exact Mass ]:
245.09300

[ PSA ]:
61.77000

[ LogP ]:
2.49770

[ Index of Refraction ]:
1.668

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YS5075000
CHEMICAL NAME :
Urea, 1-(2-chloroethyl)-1-nitroso-3-(2-norbornyl)-
CAS REGISTRY NUMBER :
13909-13-2
LAST UPDATED :
199612
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C10-H16-Cl-N3-O2
MOLECULAR WEIGHT :
245.74
WISWESSER LINE NOTATION :
L55 ATJ CMVNNO&2G

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
83 mg/kg
TOXIC EFFECTS :
Liver - jaundice, other or unclassified Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NCIMR* Progress Report Submitted to the National Cancer Institute by Mason Research Institute. (Worcester, MA) Volume(issue)/page/year: -,372,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
56 mg/kg
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NCIMR* Progress Report Submitted to the National Cancer Institute by Mason Research Institute. (Worcester, MA) Volume(issue)/page/year: -,372,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
54760 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
18750 ug/kg/15D-I
TOXIC EFFECTS :
Blood - normocytic anemia Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases
REFERENCE :
NCIMR* Progress Report Submitted to the National Cancer Institute by Mason Research Institute. (Worcester, MA) Volume(issue)/page/year: -,372,1968
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
15 mg/kg/5W-I
TOXIC EFFECTS :
Liver - change in gall bladder structure or function Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases
REFERENCE :
NCIMR* Progress Report Submitted to the National Cancer Institute by Mason Research Institute. (Worcester, MA) Volume(issue)/page/year: -,372,1968
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
35 mg/kg/15D-I
TOXIC EFFECTS :
Liver - fatty liver degeneration Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NCIMR* Progress Report Submitted to the National Cancer Institute by Mason Research Institute. (Worcester, MA) Volume(issue)/page/year: -,372,1968

Safety Information

[ HS Code ]:
2924299090

Precursor & DownStream

Precursor

  • Bicyclo[2.2.1]heptan-2-amine
  • 1-(2-chloroethyl)-3-norbornan-2-yl-urea

DownStream

Customs

[ HS Code ]: 2924299090

[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%


Related Compounds

  • 1-(2-chloroethyl)-1-nitroso-3-(2-sulfamoylethyl)urea
  • 1-(2-chloroethyl)-1-nitroso-3-(2-oxoazepan-3-yl)urea
  • 1-(2-chloroethyl)-1-nitroso-3-(2-piperidin-1-ylsulfonylethyl)urea
  • 1-(2-chloroethyl)-1-nitroso-3-(2,4,6-trimethylphenyl)urea
  • 1-(2-chloroethyl)-1-nitroso-3-(2,3,4-tri-O-acetyl-β-D-xylopyranosyl)urea
  • 1-(2-chloroethyl)-1-nitroso-3-[2-(4-octyl-2,3-dioxopiperazin-1-yl)ethyl]urea
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • Methyl 5-{[(benzyloxy)carbonyl]amino}-6-chloropyridine-2-carboxylate
  • 5-[2-Nitro-4-(trifluoromethyl)phenyl]-1,2-oxazol-4-amine
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine